We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
–
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Top Sells

Rank Stock Value
1
CCL icon
Carnival Corporation Ltd
CCL
+$24.2M
2
BLU
BELLUS Health Inc.
BLU
+$16.7M
3
ABUS icon
Arbutus Biopharma
ABUS
+$11.7M
4
NKLAW
Nikola Corporation Warrant expiring 6/3/2025
NKLAW
+$11M
5
LGVW.U
Longview Acquisition Corp. Units, each consisting of one share of Class A common stock, and one-thir
LGVW.U
+$5.79M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DIS icon
451
PUT
Walt Disney
DIS
$179B
– –
-25,000
Closed -$20K
DRI icon
452
CALL
Darden Restaurants
DRI
$24.9B
– –
-60,300
Closed -$1.02M
EBAY icon
453
CALL
eBay
EBAY
$47.2B
– –
-87,700
Closed -$381K
EOSE icon
454
Eos Energy Enterprises
EOSE
$1.54B
– –
-354,767
Closed -$3.81M
EOSEW
455
Eos Energy Enterprises Warrant
EOSEW
$31.1M
– –
-32,500
Closed -$57K
ESPR
456
CALL
DELISTED
Esperion Therapeutics
ESPR
– –
-25,000
Closed -$152K
ESPR
457
PUT
DELISTED
Esperion Therapeutics
ESPR
– –
-25,000
Closed -$34K
EVRG icon
458
CALL
Evergy
EVRG
$18.9B
– –
-10,000
Closed -$26K
F icon
459
CALL
Ford
F
$55.7B
– –
-471,700
Closed -$73K
F icon
460
Ford
F
$55.7B
– –
-110,193
Closed -$670K
F icon
461
PUT
Ford
F
$55.7B
– –
-36,000
Closed -$15K
FFIV icon
462
CALL
F5
FFIV
$23.4B
– –
-8,800
Closed -$298K
FFIV icon
463
PUT
F5
FFIV
$23.4B
– –
-7,000
Closed -$1K
FICO icon
464
CALL
Fair Isaac
FICO
$22.4B
– –
-55,700
Closed -$1.6M
FICO icon
465
Fair Isaac
FICO
$22.4B
– –
-7,701
Closed -$3.22M
FICO icon
466
PUT
Fair Isaac
FICO
$22.4B
– –
-14,700
Closed -$35K
FOLD
467
CALL
DELISTED
Amicus Therapeutics
FOLD
– –
-20,000
Closed -$68K
FOLD
468
PUT
DELISTED
Amicus Therapeutics
FOLD
– –
-10,000
Closed -$11K
FVRR icon
469
Fiverr
FVRR
$315M
– –
-12,101
Closed -$893K
GB
470
DELISTED
Global Blue Group Holding
GB
– –
-190,802
Closed -$1.95M
GCMG icon
471
GCM Grosvenor
GCMG
$844M
– –
-44,868
Closed -$487K
GDX icon
472
CALL
VanEck Gold Miners ETF
GDX
$27.5B
– –
-100,000
Closed -$315K
GDX icon
473
VanEck Gold Miners ETF
GDX
$27.5B
– –
-36,000
Closed -$1.32M
GOGO icon
474
Gogo Inc
GOGO
$392M
– –
-23,911
Closed -$76K
HIMS icon
475
Hims & Hers Health
HIMS
$7.12B
– –
-25,000
Closed -$254K
17 18
19
20 21

Similar funds

CIP
Chartwell Investment Partners Berywn, Pennsylvania $2.91B AUM 40.48% 1-Year Est. Return
PWLP
Prio Wealth Limited Partnership Boston, Massachusetts $3.41B AUM 44.09% 1-Year Est. Return
FPCG
Fort Pitt Capital Group Pittsburgh, Pennsylvania $3.55B AUM 34.86% 1-Year Est. Return
SI
Scout Investments Kansas City, Missouri $3.8B AUM 45.91% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
FTDI
First Trust Direct Indexing Boston, Massachusetts $1.87B AUM 43.63% 1-Year Est. Return
CIM
Contrarius Investment Management St. Helier, Jersey $1.76B AUM 35.87% 1-Year Est. Return
PRO
Pensioenfonds Rail & OV Utrecht, Netherlands $1.44B AUM 23.73% 1-Year Est. Return

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.